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This study aimed to comprehend the largely unknown role of voltage-gated potassium channel 1.3 (Kv1.3) in the phagocytic 
function of macrophages. We found that blocking of the Kv1.3 channel with 100 pmol L1 Stichodactyla helianthus neurotoxin 
(ShK) enhanced the phagocytic capacities of both resting and lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages in 
the chicken erythrocyte system. In the fluorescein isothiocyanate (FITC)-labeled Escherichia coli k-12 system, ShK increased 
the phagocytic capacities of resting RAW264.7 cells, but not of the LPS-stimulated cells, as LPS alone stimulated almost satu-
rated phagocytosis of the macrophages. ShK increased the nitric oxide (NO) production in LPS-activated cells, but not in rest-
ing RAW264.7 cells. There was no effect of ShK alone on the cytokine secretions in resting RAW264.7 cells, but it suppressed 
IL-1 secretion in LPS-stimulated RAW264.7 cells. At a concentration of 100 pmol L1, ShK did not affect the viability of the 
tested cells. Kv1.3 was expressed in RAW264.7 cells; this expression was downregulated by LPS, but significantly upregulat-
ed by disrupting caveolin-dependent endocytosis with filipin III. In addition, cytochalasin D, an inhibitor of actin polymeriza-
tion, did not affect the Kv1.3 expression. Thus, blocking of the Kv1.3 channel enhances the phagocytic capacity and NO pro-
duction of this cell line. Our results suggest that Kv1.3 channel serves as a negative regulator of phagocytosis in macrophages 
and can therefore be a potential target in the treatment of macrophage dysfunction. 
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Ion channels are expressed in both excitable cells and 
non-excitable cells. Compared with those in the excitable 
cells, the functions of ion channels in the non-excitable 
cells, such as immune cells, are not well documented. In 
immune cells, ion channels play key roles in the signal 
transduction chains of their immune activities. Several types 
of ion channels have been reported in T lymphocytes, in-
cluding voltage-gated K+ channel 1.3 (Kv1.3), Ca2+-    
activated K+ channel 3.1 (KCa3.1), Ca2+ release-activated 
Ca2+ (CRAC) channel, transient receptor potential me-
lastatin 7 (TRPM7) channel, and Cl channel [1]. Kv chan-
nels are widespread in various immune cells, including 
macrophages, and their actions can avoid membrane over 
depolarization and maintain the normal cell functions [2].  
Macrophage plays an important role in the immune ac-
tivities via phagocytosis, antigen-presentation, cytokines 
release, regulation of T cell signaling [3] and clearance of 
apoptotic neutrophils [4], and is involved in the pathogene-
sis of many immune- or autoimmune-related diseases in-
cluding atherosclerosis, vasculitis and hypertension [5,6]. 
Similar to that in excitable cells, changes in the membrane 
potential are among the earliest events that occur in re-
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sponse to stimulation [7] and thereby affect the functional 
activation state of macrophages. Various ion channels has 
been reported in macrophages, including Kv1.3 [8], Kv1.5 [8], 
inwardly rectifying K+ channel 2.1 (Kir2.1) [7], KCa3.1 [9], 
CRAC [10], transient receptor potential cation (TRPC) 
channel [11], and voltage-gated proton (hydrogen) channels 
(HVCN) [12]. Among these channels, the Kv channels play 
a pivotal role in the modulation of macrophage physiology [13]. 
For example, certain voltage-dependent K+ channels, such 
as Kv1.3, Kv1.5, Kir2.1, and outward delayed rectifier K+ 
channel, demonstrate differential responses during macro-
phage proliferation and activation [7]; the expression pat-
tern of Kv subunit is dependent on the proliferation and 
activation mode in macrophages [14]; Kv1.3 and Kv1.5 
co-associate and generate functional heterotetramers in 
macrophages [8]; selective Kv1.3 blockade affects the ex-
pression levels of some important cholesterol-metabolism- 
associated molecules (scavenger receptor class A, lectin- 
like oxidized low-density lipoprotein receptor-1, acetyl- 
coenzyme A acetyltransferase 1 (ACAT1), and ATP-  
binding cassette transporter A1 (ABCA1)) in human mac-
rophages exposed to ox-LDL [15]; Kv1.3 and Kv1.5 are 
involved in the induction of macrophage apoptosis [16]; and 
Kv1.3 modulates macrophage migration [17]. Kv1.3 chan-
nel is also involved in the maintenance of membrane poten-
tial, Ca2+ signaling, proliferation, and activation of immune 
cells such as macrophages [18,19]. Furthermore, it has been 
suggested that Kv1.3 may serve as a novel target in thera-
pies of asthma [20] and atherosclerosis [21].  
Despite the knowledge about these facts, the role of 
Kv1.3 in the phagocytic function of macrophage has rarely 
been investigated. In this study, we focused on compre-
hending the phagocytic function of macrophages using 
RAW264.7 cell line as the macrophage model to observe 
the role of Kv1.3 in the phagocytosis of macrophages on 
chicken erythrocytes and Escherichia coli k-12. As selective 
Kv1.3 channel agonist is not commercially available, we 
used Stichodactyla helianthus neurotoxin (ShK), a selective 
Kv1.3 channel blocker [22], to manipulate the function of 
Kv1.3 channels. Our key results demonstrated that selective 
blockade of Kv1.3 channel could increase the phagocytic 
capacity of RAW264.7 cells, which suggests that Kv1.3 
may serve as a suppresser or negative regulator of macro-
phage phagocytosis. This novel finding can significantly 
contribute toward the development of therapeutic strategies 
for diseases involving macrophage malfunction.  
1  Materials and methods 
1.1  Reagents 
Stichodactyla helianthus neurotoxin (ShK) was obtained 
from Bachem (Swiss); lipopolysaccharide (LPS), cyto-
chalasin D, filipin III, and antibody against Kv1.3 was pur-
chased from Sigma (USA); horseradish peroxidase-   
conjugated secondary antibody from Santa Cruz Biotech-
nology, Inc. (USA); 4′,6-diamidino-2-phenylindole (DAPI), 
fluo-3/AM, and fluorescein isothiocyanate (FITC)-labeled 
E. coli k-12 kit from Molecular Probes (USA); TNF- en-
zyme linked immunosorbent assay (ELISA) kit from 
Shanghai ExCell Biology (Shanghai); ELISA assay kits for 
IL-6 and IL-1 and NO assay kit from Beijing 4A Biotech 
Co., Ltd. (Beijing); cell counting kit-8 (CCK-8) from 
Dojindo (Japan); regular reagents for Western blot were 
obtained from Solarbio SciePVDFe & Technology Inc., 
Ltd., (Beijing); protein marker from New England Biolabs 
(Beijing); BCA protein assay kit and antifluorescence 
quenching agents from Beyotime Biotechnology Inc. Ltd., 
(Shanghai); and Switzerland and Giemsa staining solutions 
from Beijing Solarbio Science & Technology Co., Ltd. 
(Beijing).  
1.2  Cell culture 
The RAW264.7 cell line was purchased from the Cell Cen-
ter, Chinese Academy of Medical Sciences. Post-recovery, 
the RAW264.7 cells were cultured in Dulbecco’s modified 
Eagles medium (DMEM) supplemented with 10% fetal bo-
vine serum, 100 U mL1 penicillin, and 100 mg mL1 strep-
tomycin. The culture was maintained at 37°C under a 5% 
CO2 humidified atmosphere. Cells at 3×10
3 mL1 concen-
tration in DMEM medium were plated onto 96-well plates 
and allowed to adhere overnight. The cells were passaged 
and cultured to achieve 80% confluence for further study. 
1.3  Preparation of chicken erythrocytes 
We used nucleated chicken erythrocytes to study the role of 
Kv1.3 in the phagocytic activities of RAW264.7 macro-
phages. Chicken blood sample was harvested at a chicken 
farm. To isolate the erythrocytes, 5 mL of blood was draw 
from the chicken artery with a syringe and then transferred 
to heparinized tubes prefilled with 20 mL of Alsever solu-
tion (containing anticoagulant sodium citrate and glucose) 
to obtain a blood:Alsever solution ratio of 1:4, followed by 
mixing and storage at 4C. The blood samples were washed 
with sterile saline thrice and then centrifuged. The superna-
tant and white blood cells were discarded, and the remain-
ing erythrocytes were added to sterile saline, with a final 
volume to 4 mL. The erythrocyte solution was re-     
centrifuged, and then one drop of erythrocytes was added to 
sterile saline to make 1% concentration of the cell suspen-
sion.  
1.4  Cell viability assay 
The viability of the RAW264.7 cells was determined by the 
CCK-8 assay. To examine the role of Kv1.3 in phagocyto-
sis, the RAW264.7 cells were pre-incubated with ShK at 
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different concentrations for 24 h in a 96-well plate. Cells 
treated with saline served as control. After incubation, the 
RAW264.7 cells were cultured for 2 h in 10 μL CCK-8- 
containing culture medium. Next, the absorbance was 
measured at 450 nm with a reference wavelength of 630 nm 
on a microplate reader (Synergy 4, BioTek, USA). The cell 
viability was expressed as the percentage of control, which 
was defined to be 100%.  
1.5  Phagocytosis assay and Switzerland Giemsa stain-
ing of chicken erythrocytes  
Mature chicken erythrocytes possess nuclei that can be eas-
ily recognized under a microscope (Nikon E100, Japan) 
when phagocytosed. Switzerland Giemsa staining of chick-
en erythrocytes is an established method that allows explicit 
and quantitative measurement of cell phagocytosis. To ob-
serve the phagocytosis of RAW264.7 cells on chicken 
erythrocytes, the RAW264.7 cells (with or without ShK 
pretreatment) and chicken erythrocytes were co-cultured for 
2 h and then washed with phosphate-buffered solution 
(PBS) to remove the erythrocytes not adhering to the 
RAW264.7 cells.  
For Giemsa staining, the RAW264.7 cells were treated 
with Switzerland staining solution for 2 min at room tem-
perature. After the staining solution turned red, an equiva-
lent amount of PBS was added and the staining process was 
continued for an additional 10 min. The cells were then 
washed with PBS, air-dried, and stained with Giemsa solu-
tion for 4 min at the room temperature. The cells were then 
washed with distilled water thrice, air-dried, and covered 
with neutral gum. The phagocytosed chicken erythrocytes 
presenting inside the RAW264.7 cells were examined under 
a microscope by a person blinded to the experimental de-
sign. Three fields of each coverslip were randomly selected, 
and all phagocytosed chicken erythrocytes on each field 
were counted. The phagocytosis rate (PR), which reflects 
the mean numbers of phagocytosed erythrocytes in each 
RAW264.7 cell, was calculated according to the following 
equation: PR=(total numbers of the phagocytosed erythro-
cytes in 200 RAW264.7 cells)/200100%.  
1.6  Flow cytometry to quantitate the phagocytosis of 
RAW264.7 cells on FITC-labeled E. coli k-12  
An alternative measure was used to examine the phagocyto-
sis of the RAW264.7 cells on E. coli k-12 labeled with 
FITC. The fluorescence intensity inside the RAW264.7 
cells served as an indicator of phagocytic capacity. Briefly, 
cells culture and treatment procedures were kept the same 
as described above, except that the chicken erythrocytes 
were replaced by FITC-labeled E. coli k-12. After 
co-culturing the RAW264.7 cells with FITC- labeled E. coli 
k-12 for different time periods followed by washing with 
PBS, the RAW264.7 cells were loaded into the FACSCal-
libur flow cytometer (Becton Dickinson, USA) and the flu-
orescence of FITC-labeled E. coli inside the RAW264.7 
cells was measured with the absorption/emission maxima of 
560/585 nm at the FL-1 channel. The mean fluorescence 
intensity (MFI) was calculated by using the ImageJ soft-
ware, and the data for fluorescence activating cell sorter 
(FACS) were analyzed by the software FCS-Express ver-
sion 3.0 (De Novo).  
Two parameters of phagocytosis were calculated based 
on the flow cytometry data. (i) The phagocytosis index, 
which represents the MFI of the RAW264.7 cells, demon-
strating phagocytic activities; this parameter was an auto-
matic readout of the flow cytometer and reflected the mean 
numbers of engulfed FITC-labeled E. coli k-12 in the 
RAW264.7 cells. (ii) The percentage phagocytosis, which is 
a parameter reflecting the number of RAW264.7 cells ex-
hibiting phagocytic activities in the entire pool of 
RAW264.7 cells. In practice, the negative control is consid-
ered as the reference region, and a line is drawn at the 
right-hand side of this region. Cells distributed at the 
left-hand side of the line were identified as RAW264.7 cells 
without any phagocytic activities, while cells at the 
right-hand side of the line were identified as RAW264.7 
cells with phagocytic activities.  
1.7  NO assay 
The NO production of the RAW264.7 cells under different 
treatment conditions was estimated by using a NO assay kit. 
Briefly, the supernatant (100 μL) of 16 h culture was pre-
pared, and the nitrite content was measured by absorbance 
at 530 nm within 30 min of the last incubation. Nitrite con-
centration in the samples was calculated with reference to a 
standard curve prepared with KNO3. 
1.8  ELISA assays of TNF-, IL-6, and IL-1 
At the end of the 16-h stimulation of the RAW264.7 cells 
with different agents, the culture supernatants were har-
vested and the levels of TNF-, IL-6, and IL-1 in the su-
pernatants was measured by using the respective ELISA 
assay kits, according to the manufacturer’s instructions. 
Data reflected the secretion levels of these cytokines. 
1.9  Western blot 
The Kv1.3 protein expression levels of the RAW264.7 cells 
were determined by Western blot. Briefly, the RAW264.7 
cells were scraped and collected by centrifugation at 88.8g 
for 5 min at 4C and resuspended in a radioimmunoprecipi-
tation assay (RIPA) lysis buffer containing 50 mmol L1 
Tris-HCl (pH 7.4), 150 mmol L1 NaCl, 1% Triton X-100, 
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1% sodium deoxycholate, 0.1% sodium dodecyl sulfate 
(SDS), 2 mmol L1 ethylenediaminetetraacetate (EDTA), 
and a series of protease inhibitors including 1 mmol L1 
4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride 
(AEBSF), 800 nmol L1 aprotinin, 50 mol L1 bestanin,   
15 mol L1 E64, 20 mol L1 leupeptin and 10 mol L1 
pepstatin A. After thorough lysis on ice, the solution was 
centrifuged at 12,787g for 10 min at 4C and the superna-
tant was collected. The protein content was determined by 
the bicinchoninic acid (BCA) method using samples ali-
quoted and stored at 80°C until use for Kv1.3 protein de-
tection. A total of 50 µg of the total protein was separated 
on 10% SDS-polyacrylamide gel electrophoresis (PAGE) 
and then transferred onto polyvinylidene fluoride (PVDF) 
membrane, followed by blocking and incubation with an-
ti-Kv1.3 primary antibody (1:1,000) at 4°C overnight. The 
blots obtained were incubated with horseradish peroxi-
dase-conjugated secondary antibody (1:5,000) at the room 
temperature for 1 h, followed by development on the ECL 
system (Engreen Biosystem Co, Ltd., Beijing). Images were 
captured using the EC3 Imaging System (UVP Inc., Upland, 
USA) and quantified by Quantity One software. The influences 
of LPS (10 μg mL1 for 10 h), cytochalasin D (10 μg mL1 for 
1 h), and filipin III (5 μg mL1 for 1 h) pre-incubations on 
the Kv1.3 protein expression of the RAW264.7 cells were 
measured.  
The experimental use of animals in this study was ap-
proved by the Life Ethics Committee of Peking Union 
Medical College, and the protocol followed was in compli-
ance with the US National Institutes of Health Guidelines 
for the Care and Use of Laboratory Animals (NIH Publica-
tion 85-23). 
1.10  Statistical analyses 
Data were presented as x ±SD. Statistical analyses were 
performed using student’s t test or analysis of variance, fol-
lowed by Newman–Keuls multiple comparisons. P<0.05 
was considered to be statistically significant. 
2  Results 
2.1  Blocking of Kv1.3 channel increases phagocytosis 
of chicken erythrocytes in RAW264.7 cells  
We first adopted the classical chicken erythrocyte method to 
pharmacologically evaluate the role of Kv1.3 channel in the 
phagocytosis of RAW264.7 macrophages. For this purpose, 
we used selective Kv1.3 channel blocker ShK. Our results 
showed that the control RAW264.7 cells (without ShK 
and/or LPS treatment) demonstrated weak phagocytic activ-
ities, with most of the RAW264.7 cells not showing any 
phagocytic behaviors on chicken erythrocytes (Figure 1A),  
 
Figure 1  Typical microscopic images of Switzerland Giemsa staining 
showing the phagocytic activities of RAW264.7 cells on chicken erythro-
cytes under different conditions. A, Resting (control) untreated RAW264.7 
cells showing extremely weak phagocytic activities. B, RAW264.7 cells 
treated with ShK (100 pmol L1) for 2 h exhibiting enhanced phagocytosis. 
C, RAW264.7 cells stimulated with LPS (10 g mL1) for 16 h also show-
ing enhanced phagocytosis. D, RAW264.7 cells treated with LPS (10 g 
mL1 for 16 h) and ShK (100 pmol L1) displaying a further enhancement 
of phagocytosis in comparison with that of cells treated with LPS or ShK 
alone. The subpanels marked a–h on the right-hand side of the figure are 
enlarged images corresponding to the framed areas (also marked a–h) on 
the left-hand side of the figure. The cytoplasm of chicken erythrocytes was 
stained red, while their nuclei were stained blue (arrows). E, Statistical 
summary of the PR for different treatment conditions. **: P<0.01, vs. 
Control; #: P<0.05, vs. ShK; : P<0.05, vs. LPS; n=3 for each group. 
and the PR was found to be only (1.670.29)% (n=3). 
However, the RAW264.7 cells pretreated with ShK (100 
pmol L1 for 2 h) (the concentration of ShK was consistent-
ly 100 pmol L1 throughout the study) demonstrated an in-
creased phagocytic behavior (Figure 1B), and the numbers 
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of phag-ocytosed chicken erythrocytes in single RAW264.7 
cells were significantly increased because a single 
RAW264.7 cell can engulf several chicken erythrocytes at 
the same time (Figure 1B); the respective PR was increased 
to (4.55±0.44)% (P<0.01 vs. control, n=3). LPS (10 g mL1) 
(the concentration of LPS was consistently 10 g mL1 
throughout the study), a classical stimulator of inflammation 
and phagocytosis, evidently enhanced the phagocytic activi-
ties of the RAW264.7 cells on chicken erythrocytes, as was 
expected (Figure 1C), and the PR increased to 
(4.48±0.42)% (P<0.01 vs. control). ShK (100 pmol L1) 
further enhanced the phagocytic activities of 
LPS-stimulated RAW264.7 cells, and the numbers of phag-
ocytosed chicken erythrocytes in single RAW264.7 cells 
were significantly increased under this condition (Figure 
1D) in comparison with those under LPS treatment alone 
(Figure 1C), with the PR increased to (6.28±1.36)% 
(P<0.05 vs. LPS alone). Figure 1E presents the statistical 
summary of the PRs under different treatment conditions. 
2.2  Blocking of Kv1.3 channel enhances the phagocy-
tosis of E. coli k-12 in RAW264.7 cells  
As engulfment and elimination of bacteria is an innate im-
munological behavior of macrophages, we examined the 
phagocytic activity of RAW264.7 cells on FITC-labeled E. 
coli k-12 as well as the role of Kv1.3 in this activity by us-
ing quantitative flow cytometry assay. Our results demon-
strated that selective blockade of Kv1.3 channels by ShK 
(100 pmol L1 for 2 h) increased the phagocytic capacity of 
LPS-untreated RAW264.7 cells on FITC-labeled E. coli 
k-12, as indicated by the increased fluorescence intensity 
inside the RAW264.7 cells (Figure 2B) as compared with 
that of the control (Figure 2A and 2E). LPS alone (10 g mL1 
for 16 h) could also significantly stimulate the phagocytic 
activities of RAW264.7 cells on FITC-labeled E. coli k-12 
(Figure 2C), and this effect was greater than that of ShK in 
terms of phagocytosis index (Figure 2E). ShK (100 pmol L1 
for 2 h) appeared to increase the fluorescence intensity in 
LPS-pre-stimulated RAW264.7 cells (Figure 2D and 2E), 
although the difference was not statistically significant 
(P>0.05 vs. LPS alone) (Figure 2E).  
Alternatively, flow cytometry was used to evaluate the 
phagocytic capacity of macrophages in order to calculate 
the percentage of RAW264.7 macrophages displaying 
phagocytosis (the percentage phagocytosis). As shown in 
Figure 3, ShK (100 pmol L1) significantly increased the 
percentage phagocytosis. In addition, as a positive control 
drug, LPS (10 g mL1) also strongly increased the per-
centage phagocytosis. No further increase in the percentage 
phagocytosis was observed when ShK was co-applied with 
LPS in comparison with the corresponding effect of LPS 
application alone, probably because a saturation percentage 
(or a peak) was reached at >94% in the LPS-stimulated  
 
Figure 2  Flow cytometry assay for studying the phagocytic capacities of 
RAW264.7 cells on FITC-labeled E. coli k-12 under different treatment 
conditions. The phagocytosis index reflecting the phagocytic capacity was 
indicated by the MFI. A, Resting (control) RAW264.7 cells showing weak 
phagocytic activities on the E. coli k-12 system. Black curve and red curve 
represent the phagocytosis of RAW264.7 cells on FITC-unlabeled and 
FITC-labeled E. coli k-12, respectively. B, Enhanced phagocytosis of ShK 
(100 pmol L1 for 2h)-pretreated RAW264.7 cells on FITC-labeled E. coli 
(blue curve) in comparison to that of ShK-untreated cells (red curve). C, 
LPS (10 g mL1 for 16 h)-stimulated RAW264.7 cells exhibiting en-
hanced phagocytosis on FITC-labeled E. coli (yellow curve). D, 
RAW264.7 cells pre-treated with ShK (100 pmol L1 for 2 h) and LPS (10 
g mL1 for 16 h) yielding similar enhancement in phagocytosis as that 
with LPS treatment alone (P>0.05). E, Statistical bar graph reflecting the 
MFI in each treatment group (n=3), indicating the quantities of engulfed E. 
coli. *: P<0.05, vs. Control; ##: P<0.01 vs. ShK. 
RAW264.7 cells. These results are consistent with those of 
the erythrocyte assay, suggesting that Kv1.3 may be a nega-
tive regulator of the phagocytosis of RAW264.7 cells.  
2.3  Blocking of Kv1.3 channel increases NO produc-
tion in LPS-stimulated RAW264.7 cells 
As nitric oxide (NO) is an important indicator of macro-
phage activation, we studied the NO production by  
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Figure 3  Flow cytometry assay was performed to evaluate the percentage phagocytosis of RAW264.7 cells under different treatment conditions. A–E, 
Represents the results of flow cytometry. Negative, the E. coli k-12 system was not labeled with FITC, therefore the phagocytosis percentage was set to 0.0%. 
Control, RAW264.7 cells without drug treatment, but with E. coli k-12 labeled with FITC, indicating that the resting cells demonstrated phagocytic behav-
iors to some extent. ShK, RAW264.7 cells treated with ShK (100 pmol L1). LPS, RAW264.7 cells treated with LPS (10 g mL1). ShK+LPS, RAW264.7 
cells treated with ShK (100 pmol L1) and LPS (10 g mL1). The percentage value given inside each subpanel is the respective value of percentage phago-
cytosis. The red line segment in each subpanel indicates the area in which the phagocytosed FITC-labeled E. coli k-12 would appear. F, Statistical summary 
of the percentage phagocytosis for different treatments (n=3 for each treatment). **: P<0.01, vs. Negative; ##: P<0.01, vs. Control; NS: not significant. 
RAW264.7 cells under different treatment conditions. 
Compared with the control (resting) cells, LPS (10 g mL1 
for 16 h)-stimulated RAW264.7 cells showed significant 
increase in the NO production, with an increase in the NO 
level from (1.85±0.01) mmol L1 (control) to (35.11±0.87) 
mmol L1 (P<0.01) (Figure 4A), suggesting that, LPS, a 
known activator of macrophages, can significantly stimulate 
NO production in RAW264.7 cells. ShK (100 pmol L1) 
alone could not stimulate the NO production in resting 
RAW264.7 cells (Figure 4A), but it enhanced the NO pro-
duction in LPS-stimulated RAW264.7 cells (Figure 4A), with 
an increase from the control level of (35.11±0.87) mmol L1 to 
(41.27±0.42) mmol L1 (P<0.05) (Figure 4A). These results 
are consistent with those of the phagocytosis assays, to-
gether suggesting that activation of Kv1.3 channel may ex-
ert an inhibitory effect on NO production of RAW264.7 
cells upon LPS stimulation. 
2.4  Blocking of Kv1.3 channel did not significantly 
affect cell viability and secretions of TNF- and IL-6, 
but it decreased LPS-induced IL-1 secretion in 
RAW264.7 cells  
CCK-8 assay was performed to assess the role of Kv1.3 in 
macrophage viability. ShK treatment (100 pmol L1 for 24 h) 
did not significantly affect the viability of RAW264.7 cells 
(Figure 4B).  
Double antibodies-sandwich enzyme-linked immuno-
sorbent assay (ELISA) was performed on the culture super-
natant to examine cytokine secretion. As TNF- is an in-
flammatory cytokine released by macrophages on activa-
tion, we also accessed whether Kv1.3 plays a role in TNF- 
production by RAW264.7 cells. ShK (100 pmol L1) alone 
could not induce TNF- release relative to the control (Fig-
ure 4C). As a well-known stimulator of TNF- released in 
macrophages, LPS (10 pg mL1) significantly increased the 
secretion of TNF- by RAW264.7 cells than that of 
LPS-untreated control cells (Figure 4C). At the same con-
centration, ShK treatment could not further increase the 
TNF- production in LPS-stimulated RAW264.7 cells 
(Figure 4C), probably because LPS had already stimulated 
maximal TNF- production or that ShK did not have any 
effect on the TNF-α production.  
LPS (10 g mL1) significantly increased the secretions 
of IL-6 (Figure 4D) and IL-1 (Figure 4E) in RAW264.7 
cells. ShK (100 pmol L1) alone did not significantly affect 
the secretions of IL-6 (Figure 4D) and IL-1 (Figure 4E), 
rather suppressed the LPS-induced secretion of IL-1 in  
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Figure 4  Effects of Kv1.3 blockade on NO production, cell viability, and 
cytokines secretion in RAW264.7 cells. A, NO assay. B, CCK-8 assay 
demonstrating cell viability, relative to that of the control cells set to 100%. 
C–E, ELISA assays indicating the secretions of TNF-, IL-6, and IL-1, 
respectively. **: P<0.01, vs. Control; ##: P<0.01, vs. LPS; NS: not signif-
icant (vs. Control); n=3 for each treatment. Drug concentrations: SHK, 100 
pmol L1; LPS, 10 g mL1. 
RAW264.7 cells (Figure 4E).  
2.5  Kv1.3 is expressed in RAW264.7 cells and is up-
regulated by disrupting the caveolin-dependent endocy-
tosis pathway  
Western blot revealed that LPS (10 μg mL1), an activator 
of endocytosis, moderately decreased the protein expression 
level of Kv1.3 in RAW264.7 cells (Figure 5). Filipin III  
(5 μg mL1), an inhibitor of caveolin-dependent endocyto-
sis, strongly stimulated the protein expression of Kv1.3 in 
RAW264.7 cells (Figure 5). Cytochalasin D (10 μg mL1), 
an inhibitor of actin polymerization, did not affect Kv1.3 
expression relative to that in the control RAW264.7 cells 
(Figure 5). These results suggest that the pathway of caveo-
lin-dependent endocytosis is associated with the protein 
expression of Kv1.3 in RAW264.7 macrophages. 
3  Discussion 
Kv1.3 channel is involved in the regulations of membrane 
potential, Ca2+ signaling, immune response [1], and T cell 
activation, adhesion, and migration [23]. Lei et al. [21] re-
ported that blocking of Kv1.3 channel by margatoxin could 
suppress the transition of mononuclear macrophages to 
foam cells, which suggested Kv1.3 channel is a therapeutic   
 
Figure 5  Western blot revealed the protein expression of Kv1.3 in 
RAW264.7 cells at different treatment conditions. The upper panel repre-
sents electrophoresis bands. The lower panel shows the statistical bar graph 
of Kv1.3 expression levels. **: P<0.01, vs. Control; ##: P<0.01; NS: not 
significant; n=3 for each treatment; Cyt. D: cytochalasin D. 
target of atherosclerosis. Despite these findings, the func-
tions of Kv1.3 channel in the macrophages, including that 
on phagocytosis, remains to be addressed fully. The present 
study focused on the action of Kv1.3 channel in macro-
phage phagocytosis. For the first time, we found that, under 
different treatment conditions, blocking of Kv1.3 channel 
increases the phagocytic capacity of RAW264.7 macro-
phages. Our results strongly suggest that Kv1.3 channel acts 
as a negative regulator of phagocytosis. We further demon-
strated that the negative regulation of phagocytosis by 
Kv1.3 channel is associated with NO production in activat-
ed, but not resting, RAW264.7 cells. However, because 
Kv1.3 channel agonist is commercially unavailable at pre-
sent, we could not demonstrate the direct effect of Kv1.3 
channel activation on the phagocytosis of macrophages. 
We employed two phagocytosis systems to identify the 
role of Kv1.3 channel in the phagocytic behaviors of 
RAW264.7 macrophages: the chicken erythrocyte system 
and the E. coli system. The chicken erythrocyte system [24] 
is commonly used to measure phagocytosis owing to the 
unique advantage of visibility of nucleated chicken eryth-
rocytes under a microscope. Through this approach, it is 
easy to calculate the numbers of macrophages displaying 
phagocytic behaviors and the numbers of erythrocytes 
phagocytosed by a macrophage. The E. coli method [25] is 
also a popular measurement approach of phagocytosis, as 
bacterial phagocytosis is an innate immune activity in infec-
tious diseases. Using flow cytometry, the E. coli method can 
accurately and quantitatively estimate the phagocytic activi-
ties of macrophages both in vitro and in vivo [26]. In the 
present study, we used both these methods and found that 
the results of these two experiments were compatible, sug-
gesting that blocking of Kv1.3 channel by ShK enhances the  
874 Zhu H, et al.   Sci China Life Sci   September (2015) Vol.58 No.9 
phagocytic activities of RAW264.7 macrophages either on 
chicken erythrocytes or on FITC-labeled E. coli k-12. The 
two measurement techniques reciprocally verified the role 
of Kv1.3 channel in phagocytosis.  
The phagocytic activities of macrophages are precisely 
controlled and regulated under normal conditions, and any 
dysfunction in the macrophages (overactivity or depressed 
activity) may lead to or aggravate diseases. Macrophage 
activation syndrome (MAS) [27] is an example of a disease 
involving macrophage overactivation. Suppressed phago-
cytic activities of macrophages are often observed, for exam-
ple, in the liver Kupffer cells after trauma-hemorrhage [28] 
and in the alveolar macrophages in chronic obstructive 
pulmonary disease (unpublished data). Therefore, regulation 
of the phagocytic capacity of macrophages is an important 
approach toward treatment of diseases involving macro-
phage malfunction. We found that blocking of Kv1.3 chan-
nel could increase the phagocytic capacity of RAW264.7 
macrophages, which suggests that Kv1.3 may be a potential 
drug target for adjusting macrophage malfunction in certain 
diseases. On the other hand, direct opening of Kv1.3 chan-
nels by selective Kv1.3 channel agonist may potentially 
exert an opposite effect on the phagocytic capacity of mac-
rophages as compared with that by Kv1.3 channel blockade. 
However, studies on the development of selective Kv1.3 
channel agonist are ongoing. A limitation of the present 
study includes failure to directly record Kv1.3 currents for 
evaluating whether the enhanced phagocytosis induced by 
ShK is caused by a decrease in the Kv1.3 currents. 
We further found that blocking of the Kv1.3 channel by 
ShK treatment did not significantly affect the NO produc-
tion in resting RAW264.7 cells, although it enhanced the 
NO production in LPS-stimulated RAW264.7 cells. This 
phenomenon is consistent with the observation of phagocy-
tosis capacity in resting RAW264.7 cells, which is a weak 
phagocytic behavior either on chicken erythrocytes or on E. 
coli, while LPS-activated RAW264.7 cells exhibited strong 
phagocytosis, and ShK yielded greater enhancement on the 
phagocytic capacity of LPS-activated RAW264.7 cells than 
on the resting RAW264.7 cells. These results suggest that 
NO exerts some effects on the Kv1.3 channel activity,  
considering that LPS induces NO release, which is in turn 
associated with Ca2+ mobilization and macrophage activa-
tion [29]. Moreover, the plasmic Ca2+ level exerts a feed-
back effect on the Kv channel activities.  
Phagocytosis occurs as an inflammatory response to 
pathogenic factors in several diseases, and cytokine secre-
tion by macrophages is one of the key behaviors of macro-
phages during inflammation [30]. On the basis of our find-
ing that Kv1.3 modulates the phagocytic behavior of mac-
rophages, we speculate that Kv1.3 may also affect cytokine 
secretions in macrophages. This hypothesis is supported by 
our observation that blocking of Kv1.3 channel with ShK 
treatment decreased the secretion of IL-1 in LPS-stimu- 
lated RAW264.7 cells. ShK itself did not significantly affect 
the secretions of TNF-, IL-6, and IL-1 in resting 
RAW264.7 cells that suggests that modulation of certain 
cytokine secretion by Kv1.3 channel is macrophage activa-
tion-dependent and that Kv1.3 channel participates in the 
inflammatory responses of macrophages. Activation of 
Kv1.3 channel may potentially exert a suppressing effect on 
the hyperactive innate immune and inflammatory responses 
as well as on cytokine storm in certain diseases [31,32]. 
In addition to the direct channel activation or blockade, 
the channel protein expression level may also influence the 
function of the channel. In the present study, LPS signifi-
cantly decreased the expression of Kv1.3 in RAW264.7 
cells, suggesting that macrophage activation exerts a nega-
tive feedback effect on the Kv1.3 expression. As a mem-
brane protein, Kv1.3 undergoes recycling across the mem-
brane via endocytosis and recycling, and it is possible that 
some specific endocytosis pathways are involved in these 
processes. We previously have identified the internalization 
pathways by which RAW264.7 macrophages intake Fe2O3 
nanoparticles [33]. In the present study, we found that 
blocking the caveolin-dependent endocytosis pathway by 
filipin III could strongly enhance the Kv1.3 expression in 
RAW264.7 cells, although blocking actin polymerization by 
cytochalasin D did not affect the Kv1.3 expression. Some 
investigators have reported that cytochalasin D suppresses 
the activities of Cdc42 and Rac [34], which are the two 
transcription factors involved in the LPS-activation of mac-
rophages. Despite differential results, our observations sug-
gest that certain endocytosis pathway(s), especially the 
pathway of caveolin-dependent endocytosis, is involved in 
the regulation of Kv1.3 membrane expression, although the 
underlying mechanisms of the same need further investiga-
tion. Notably, change in the channel expression is not nec-
essarily equivalent to change in channel activation. There-
fore, manipulating channel activation status by using a 
channel opener or blocker cannot be displaced by manipu-
lating the channel expression via gene molecular strategies.  
In this study, we used LPS as an activator of macrophag-
es and as a positive control drug. LPS could induce macro-
phage activation and IL release as well as increase the 
Kv1.3/Kv1.5 ratio [35]. LPS-induced activation of macro-
phages increased the Kv1.3 currents, but decreased the 
Kir2.1 currents, and TNF- mimicked LPS effects [36]. 
These past studies support that LPS activates Kv1.3 chan-
nels and that manipulating the Kv1.3 channel activities may 
exert a regulatory effect on the phagocytic activities of 
macrophages. 
In summary, we found that blocking of Kv1.3 channel by 
ShK treatment increases the phagocytic capacity and NO 
production, but decreases IL-1 secretion, in LPS-    
stimulated RAW264.7 macrophages. The expression of 
Kv1.3 in RAW264.7 macrophages was downregulated by 
LPS, but it was upregulated by blocking of caveo-
lin-dependent endocytosis with filipin III. The cumulative 
results suggest that Kv1.3 is a negative regulator of macro-
phage phagocytosis that may serve as a target for modulat-
ing the phagocytic capacity of macrophages.  
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